Abstract
Age related muscle loss, known as sarcopenia, is a major factor in disability, loss of mobility and quality of life in the elderly. There are many proposed mechanisms of age-related muscle loss that include the endocrine system. A variety of hormones regulate growth, development and metabolism throughout the lifespan. Hormone activity may change with age as a result of reduced hormone secretion or decreased tissue responsiveness. This review will focus on the complex interplay between the endocrine system, aging and skeletal muscle and will present possible benefits of therapeutic interventions for sarcopenia.
Keywords: aging, endocrine, exercise, growth hormone, hormones, sarcopenia, testosterone, vitamin D, estrogen, muscle
Current Aging Science
Title: The Endocrine System and Sarcopenia: Potential Therapeutic Benefits
Volume: 4 Issue: 3
Author(s): Kevin L. McIntire and Andrew R. Hoffman
Affiliation:
Keywords: aging, endocrine, exercise, growth hormone, hormones, sarcopenia, testosterone, vitamin D, estrogen, muscle
Abstract: Age related muscle loss, known as sarcopenia, is a major factor in disability, loss of mobility and quality of life in the elderly. There are many proposed mechanisms of age-related muscle loss that include the endocrine system. A variety of hormones regulate growth, development and metabolism throughout the lifespan. Hormone activity may change with age as a result of reduced hormone secretion or decreased tissue responsiveness. This review will focus on the complex interplay between the endocrine system, aging and skeletal muscle and will present possible benefits of therapeutic interventions for sarcopenia.
Export Options
About this article
Cite this article as:
L. McIntire Kevin and R. Hoffman Andrew, The Endocrine System and Sarcopenia: Potential Therapeutic Benefits, Current Aging Science 2011; 4 (3) . https://dx.doi.org/10.2174/1874609811104030298
DOI https://dx.doi.org/10.2174/1874609811104030298 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cachexia and Herbal Medicine: Perspective
Current Pharmaceutical Design Laparoscopic Reconstructive Surgery in Pediatric Urology: An Overview of Current Options
Current Pediatric Reviews In Silico Studies on DARC
Infectious Disorders - Drug Targets Combination of Phytochemicals as Adjuvants for Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Molecular Tests for the Choice of Cancer Therapy
Current Pharmaceutical Design The 18 kDa Translocator Protein (TSPO): A New Perspective in Mitochondrial Biology
Current Molecular Medicine Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer
Combinatorial Chemistry & High Throughput Screening Hormetic Potential of Sulforaphane (SFN) in Switching Cells’ Fate Towards Survival or Death
Mini-Reviews in Medicinal Chemistry Ghrelin: A Molecular Target for Weight Regulation, Glucose and Lipid Metabolism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Designing Prodrugs Based on Special Residues of Human Serum Albumin
Current Topics in Medicinal Chemistry The Therapeutic Potential of Small Activating RNAs for Colorectal Carcinoma
Current Gene Therapy G Protein-Coupled Receptors in Regulation of Body Weight
CNS & Neurological Disorders - Drug Targets The Male Peripubertal Phase as a Developmental Window for Reproductive Toxicology Studies
Current Pharmaceutical Design Environmentally Sensitive Paramagnetic and Diamagnetic Contrast Agents for Nuclear Magnetic Resonance Imaging and Spectroscopy
Current Topics in Medicinal Chemistry Indoleamine 2,3-dioxygenase, Tregs and Cancer
Current Medicinal Chemistry Cyclin Dependent Kinase 1 Inhibitors: A Review of Recent Progress
Current Medicinal Chemistry Current Status of Leukemia Cytotherapy - Exploitation with Immune Cells
Current Stem Cell Research & Therapy Lipid Rafts and Fas/CD95 Signaling in Cancer Chemotherapy
Recent Patents on Anti-Cancer Drug Discovery Novel Therapeutic Targets for Somatostatin in Inflammatory Chronic Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Potential of Gene Therapy for the Treatment of Pituitary Tumors
Current Gene Therapy